BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29025373)

  • 1. The prognostic value of high sensitive cardiac troponin I in patients receiving cardiac resynchronisation therapy.
    Kerekanič M; Hudák M; Mišíková S; Komanová E; Bohó A; Kyselovič J; Stančák B
    Acta Cardiol; 2018 Apr; 73(2):141-146. PubMed ID: 29025373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of serial measurements of highly sensitive cardiac troponin I in stable outpatients with nonischemic chronic heart failure.
    Kawahara C; Tsutamoto T; Sakai H; Nishiyama K; Yamaji M; Fujii M; Yamamoto T; Horie M
    Am Heart J; 2011 Oct; 162(4):639-45. PubMed ID: 21982655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure.
    Tsutamoto T; Kawahara C; Nishiyama K; Yamaji M; Fujii M; Yamamoto T; Horie M
    Am Heart J; 2010 Jan; 159(1):63-7. PubMed ID: 20102868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head-to-head comparison of high-sensitivity troponin T and sensitive-contemporary troponin I regarding heart failure risk stratification.
    de Antonio M; Lupón J; Galán A; Vila J; Zamora E; Urrutia A; Díez C; Coll R; Altimir S; Bayes-Genis A
    Clin Chim Acta; 2013 Nov; 426():18-24. PubMed ID: 23978483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-sensitivity cardiac troponin T is superior to troponin I in the prediction of mortality in patients without acute coronary syndrome.
    Árnadóttir Á; Vestergaard KR; Pallisgaard J; Sölétormos G; Steffensen R; Goetze JP; Iversen K
    Int J Cardiol; 2018 May; 259():186-191. PubMed ID: 29477263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Interpretation of Elevated Concentrations of Cardiac Troponin T, but Not Troponin I, in Nursing Home Residents.
    Cardinaels EP; Daamen MA; Bekers O; ten Kate J; Niens M; van Suijlen JD; van Dieijen-Visser MP; Brunner-La Rocca HP; Schols JM; Mingels AM
    J Am Med Dir Assoc; 2015 Oct; 16(10):884-91. PubMed ID: 26255708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of high-sensitivity cardiac troponin I in heart failure patients with mid-range and reduced ejection fraction.
    Lokaj P; Spinar J; Spinarova L; Malek F; Ludka O; Krejci J; Ostadal P; Vondrakova D; Labr K; Spinarova M; Pavkova Goldbergova M; Miklikova M; Helanova K; Parenicova I; Jakubo V; Benesova K; Miklik R; Jarkovsky J; Ondrus T; Parenica J
    PLoS One; 2021; 16(7):e0255271. PubMed ID: 34329368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac troponin I levels measured with a high-sensitive assay increase over time and are strong predictors of mortality in an elderly population.
    Eggers KM; Venge P; Lindahl B; Lind L
    J Am Coll Cardiol; 2013 May; 61(18):1906-13. PubMed ID: 23500239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-sensitivity cardiac troponin I and risk of cardiovascular disease in an Australianpopulation-based cohort.
    Zhu K; Knuiman M; Divitini M; Murray K; Lim EM; St John A; Walsh JP; Hung J
    Heart; 2018 Jun; 104(11):895-903. PubMed ID: 29066610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Sensitivity Cardiac Troponin I Levels and Prediction of Heart Failure: Results From the BiomarCaRE Consortium.
    Yan I; Börschel CS; Neumann JT; Sprünker NA; Makarova N; Kontto J; Kuulasmaa K; Salomaa V; Magnussen C; Iacoviello L; Di Castelnuovo A; Costanzo S; Linneberg A; Söderberg S; Zeller T; Ojeda-Echevarria FM; Blankenberg S; Westermann D
    JACC Heart Fail; 2020 May; 8(5):401-411. PubMed ID: 32171759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Troponin, A Predictor of Mortality in Methadone Exposure: An Observational Prospective Study.
    Sheibani M; Mirfallah Nassiri AA; Abedtash A; McDonald R; Zamani N; Hassanian-Moghaddam H
    J Am Heart Assoc; 2021 Apr; 10(8):e018899. PubMed ID: 33821671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated level of high-sensitivity cardiac troponin I as a predictor of adverse cardiovascular events in patients with heart failure with preserved ejection fraction.
    Hu H; Li J; Wei X; Zhang J; Wang J
    Chin Med J (Engl); 2023 Sep; 136(18):2195-2202. PubMed ID: 37279378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The absolute and relative changes in high-sensitivity cardiac troponin I are associated with the in-hospital mortality of patients with fulminant myocarditis.
    Liu C; Wang Z; Chen K; Cui G; Chen C; Wang L; Jiang J
    BMC Cardiovasc Disord; 2021 Nov; 21(1):571. PubMed ID: 34847863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of high-sensitivity cardiac troponin I in patients with non-ischaemic heart failure: insights from China.
    Tian P; Zhao X; Huang L; Feng J; Zhao L; Liang L; Huang B; Zhang Y; Zhang J
    ESC Heart Fail; 2022 Oct; 9(5):3345-3357. PubMed ID: 35831235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of outcome prediction of hospitalized patients with COVID-19 by a dual marker strategy using high-sensitive cardiac troponin I and copeptin.
    Kaufmann CC; Ahmed A; Kassem M; Freynhofer MK; Jäger B; Aicher G; Equiluz-Bruck S; Spiel AO; Vafai-Tabrizi F; Gschwantler M; Fasching P; Wojta J; Giannitsis E; Huber K
    Clin Res Cardiol; 2022 Mar; 111(3):343-354. PubMed ID: 34782921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic use of cardiac troponin T and troponin I in patients with heart failure.
    Healey JS; Davies RF; Smith SJ; Davies RA; Ooi DS
    Can J Cardiol; 2003 Mar; 19(4):383-6. PubMed ID: 12704483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of sex on the prognostic value of high-sensitivity cardiac troponin I in the general population: the HUNT study.
    Omland T; de Lemos JA; Holmen OL; Dalen H; Benth JŠ; Nygård S; Hveem K; Røsjø H
    Clin Chem; 2015 Apr; 61(4):646-56. PubMed ID: 25695851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitive cardiac troponin in the diagnosis and risk stratification of acute heart failure.
    Arenja N; Reichlin T; Drexler B; Oshima S; Denhaerynck K; Haaf P; Potocki M; Breidthardt T; Noveanu M; Stelzig C; Heinisch C; Twerenbold R; Reiter M; Socrates T; Mueller C
    J Intern Med; 2012 Jun; 271(6):598-607. PubMed ID: 21988283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right ventricular function and survival following cardiac resynchronisation therapy.
    Leong DP; Höke U; Delgado V; Auger D; Witkowski T; Thijssen J; van Erven L; Bax JJ; Schalij MJ; Marsan NA
    Heart; 2013 May; 99(10):722-8. PubMed ID: 23315608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of transvenous cardiac resynchronization therapy device implantation on cardiac troponin I release.
    Altin T; Akyurek O; Vurgun K; Beton O; Sayin T; Kilickap M; Karaoguz R; Guldal M; Erol C
    Pacing Clin Electrophysiol; 2007 Nov; 30(11):1356-62. PubMed ID: 17976099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.